Generic Name: fingolimod
Common side effects of Gilenya include: infection, back pain, diarrhea, increased serum alanine aminotransferase, increased serum aspartate aminotransferase, and increased liver enzymes. Other side effects include: blurred vision, bradycardia, bronchitis, increased gamma-glutamyl transferase, lymphocytopenia, migraine, dizziness, dyspnea, hypertension, increased serum transaminases, and tinea.  See below for a comprehensive list of adverse effects.
Applies to fingolimod: oral capsule
In addition to its needed effects, some unwanted effects may be caused by fingolimod (the active ingredient contained in Gilenya). In the event that any of these side effects do occur, they may require medical attention.
You should check with your doctor immediately if any of these side effects occur when taking fingolimod:
Some of the side effects that can occur with fingolimod may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:


Applies to fingolimod: oral capsule
The most common adverse events were headache, influenza, diarrhea, back pain, liver transaminase elevations, and cough.[Ref]
Common (1% to 10%): Hypertension, first degree AV block, bradycardia Uncommon (0.1% to 1%): Symptomatic bradycardia, second degree AV blockRare (0.01% to 0.1%): Peripheral arterial occlusive diseaseVery rare (less than 0.01%): Hemophagocytic syndrome Frequency not reported: Heart rate decrease, Mobitz type I (Wenckebach) block, Mobitz type II blockPostmarketing reports: Third degree AV block, AV block with junctional escape, transient asystole, peripheral arterial occlusive disease[Ref]
In the majority of cases, elevations in liver enzymes occurred within 6 to 9 months and returned to normal within approximately 2 months following discontinuation of fingolimod (the active ingredient contained in Gilenya) [Ref]
Very common (10% or more): ALT/AST increased (14%)Common (1% to 10%): Elevation in liver transaminases, GGT increased, hepatic enzyme increased, liver function test abnormal[Ref]
Infections occurred at a rate similar to placebo.[Ref]
Very common (10% or more): Influenza viral infection (13%), sinusitis (10.9%), infectionsCommon (1% to 10%): Herpes viral infection, bronchitis, gastroenteritis, tinea infection Uncommon (0.1% to 1%): PneumoniaFrequency not reported: Fatal herpetic infection, fatal varicella zoster virus infection[Ref]
Symptoms of posterior reversible encephalopathy syndrome included sudden onset of severe headache, altered mental status, visual disturbances, and seizure.[Ref]
Very common (10% or more): Headache (25%)Common (1% to 10%): Dizziness, paresthesia, migraine Rare (less than 0.1%): Posterior reversible encephalopathy syndrome, ischemic and hemorrhagic stroke Frequency not reported: Neurological atypical disordersPostmarketing reports: Syncope[Ref]
Very common (10% or more): Diarrhea (12%)[Ref]
Common (1% to 10%): Lymphopenia, leukopeniaUncommon (0.1% to 1%): Neutrophil count decreased[Ref]
Macular edema occurred at a dramatically higher rate in patients with a history of uveitis.[Ref]
Common (1% to 10%): Vision blurred, eye painUncommon (0.1% to 1%): Macular edema[Ref]
Very common (10% or more): Cough (10%)Common (1% to 10%): Dyspnea, reduction in diffusion lung capacity, reduction in FEV1[Ref]
Very common (10% or more): Back pain (12%)[Ref]
Common (1% to 10%): Alopecia, eczema, pruritus[Ref]
Common (1% to 10%): Weight decreased, blood triglycerides increased[Ref]
Common (1% to 10%): Asthenia Postmarketing reports: Unexplained death[Ref]
Common (1% to 10%): DepressionUncommon (0.1% to 1%): Depressed mood[Ref]
Frequency not reported: Lymphoma[Ref]
Postmarketing reports: Rash, urticaria, angioedema
1. "Product Information. Gilenya (fingolimod)." Novartis Pharmaceuticals, East Hanover, NJ. 
2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0
3. Cerner Multum,  Inc. "Australian Product Information." O 0
Not all side effects for Gilenya may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

Blurred vision
chills
cough
cough-producing mucus
diarrhea
difficult or labored breathing
dizziness
fever
general feeling of discomfort or illness
headache
joint pain
loss of appetite
muscle aches and pains
nausea
nervousness
pounding in the ears
runny nose
shivering
slow or fast heartbeat
sore throat
sweating
tightness in the chest
trouble sleeping
unusual tiredness or weakness
vomiting


Black, tarry stools
burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
chest pain or discomfort
cough or hoarseness
headache, severe and throbbing
lightheadedness, dizziness, or fainting
lower back or side pain
painful or difficult urination
sores, ulcers, or white spots on the lips or in the mouth
swollen glands
unusual bleeding or bruising


Weight loss
yellow skin and eyes


Back pain
pain or tenderness around the eyes and cheekbones
stuffy nose


Abdominal or stomach pain
decreased weight
depression
eye pain
hair loss or thinning of the hair
itching in the genital or other skin areas
itching skin
lack or loss of strength
scaling
skin rash, encrusted, scaly, and oozing
weakness

